Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$686,910
+$40,652 QoQ
Shares Held
5,437
+17.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,238
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. GILD ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
5,437 | $686,910 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $686,910 | 5,437 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $646,258 | 4,637 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $573,932 | 4,676 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $516,705 | 4,655 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $522,308 | 4,711 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $532,237 | 4,750 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $434,508 | 4,704 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $384,741 | 4,589 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $316,909 | 4,619 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $358,558 | 4,895 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $391,278 | 4,830 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $356,189 | 4,753 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $362,306 | 4,701 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $381,579 | 4,599 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $394,995 | 4,601 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $296,790 | 4,811 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $294,339 | 4,762 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $273,291 | 4,597 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $326,381 | 4,495 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $314,045 | 4,496 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $309,525 | 4,495 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $290,511 | 4,495 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $261,296 | 4,485 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $283,407 | 4,485 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $348,076 | 4,524 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $382,397 | 5,115 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||